A carregar...
Cisplatin is retained in the cochlea indefinitely following chemotherapy
Cisplatin chemotherapy causes permanent hearing loss in 40–80% of treated patients. It is unclear whether the cochlea has unique sensitivity to cisplatin or is exposed to higher levels of the drug. Here we use inductively coupled plasma mass spectrometry (ICP-MS) to examine cisplatin pharmacokinetic...
Na minha lista:
Publicado no: | Nat Commun |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group UK
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698400/ https://ncbi.nlm.nih.gov/pubmed/29162831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-01837-1 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|